Fundraising Fox
/People
Sign in

Karen Hong

Investor

Former Senior Investment Director, Takeda Ventures, Inc. at Takeda Ventures · Former Partner at De Novo Ventures

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to Karen

585 people in our graph can introduce you to Karen.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Anna Turetsky to introduce you to Karen

You →Anna · together at Cyteir Therapeutics (2019) →Karen

Ask Jamie Chen to introduce you to Karen

You →Jamie · 8 people · together at University of California, Berkeley →Karen

Ask Sam Okafor to introduce you to Karen

You →Sam · 2 people · together at De Novo Ventures →Karen

Sign up to find every way you can get introduced to Karen

  • Your email: the people you already email who know Karen
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Karen
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Experience

  1. Cold Spring Bio LLCCo-Foundercurrent2024 — presentNewton, Massachusetts, United States
  2. Novo VenturesPartner2019 — 2024Boston, Massachusetts, United States
  3. Cyteir TherapeuticsBoard Member2019 — 2021Lexington, Massachusetts, United States
  4. TakedaSenior Investment Director, Takeda Ventures, Inc.2017 — 2019Greater Boston
  5. Clarus TherapeuticsBoard Director2011 — 2016Northbrook, IL
  6. Agile TherapeuticsBoard Director2006 — 2016Princeton, NJ
  7. ProQuest InvestmentsPartner2001 — 2016Princeton, NJ
  8. Gloucester PharmaceuticalsBoard Observer2004 — 2010Cambridge, MA

Skills & more

Valuation3Private Equity13Pharmaceutical Industry11Commercialization7Mergers & Acquisitions17Due Diligence1Hedge Funds1Business Strategy3Strategy6Medical Devices3Start-ups4Entrepreneurship2
+8 moreCorporate DevelopmentInvestment BankingVenture FinancingInvestmentsFinancial ModelingBusiness DevelopmentStrategic PlanningTechnology Transfer

Languages English · French · Mandarin Chinese

From Karen's professional profile.

Investments

Per curated public sources.

Frequently asked questions

Who is Karen Hong?
Partner at De Novo Ventures
What check size does Karen Hong write?
Karen Hong typically writes checks of $100K – $5M.
What companies has Karen Hong invested in?
Investments tracked here include Agile Therapeutics, Cyteir Therapeutics, Oncusp Therapeutics, Stridebio.
Where did Karen Hong go to school?
Karen Hong studied at Massachusetts Institute of Technology (Ph.D., Molecular Biology); University of California, Berkeley (Bachelor's Degree, B.S. Chemistry and B.A. Molecular Biology).

Same school

Shared employers